These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31408769)

  • 1. Measuring, valuing and including forgone childhood education and leisure time costs in economic evaluation: Methods, challenges and the way forward.
    Andronis L; Maredza M; Petrou S
    Soc Sci Med; 2019 Sep; 237():112475. PubMed ID: 31408769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The friction-cost method : replacement for nothing and leisure for free?
    Brouwer WB; Koopmanschap MA
    Pharmacoeconomics; 2005; 23(2):105-11. PubMed ID: 15748085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.
    Posnett J; Jan S
    Health Econ; 1996; 5(1):13-23. PubMed ID: 8653189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of physical activity-related injuries in Dutch children aged 10-12.
    Collard DC; Verhagen EA; van Mechelen W; Heymans MW; Chinapaw MJ
    Br J Sports Med; 2011 Oct; 45(13):1058-63. PubMed ID: 21685503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method.
    Landfeldt E; Zethraeus N; Lindgren P
    Appl Health Econ Health Policy; 2019 Feb; 17(1):15-24. PubMed ID: 30105745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring time costs in interventions designed to reduce behavior problems among children and youth.
    Foster EM; Johnson-Shelton D; Taylor TK
    Am J Community Psychol; 2007 Sep; 40(1-2):64-81. PubMed ID: 17592769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time Is Money: Investigating the Value of Leisure Time and Unpaid Work.
    Verbooy K; Hoefman R; van Exel J; Brouwer W
    Value Health; 2018 Dec; 21(12):1428-1436. PubMed ID: 30502787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value for money in the health sector: the contribution of primary health care.
    Mills A; Drummond M
    Health Policy Plan; 1987 Jun; 2(2):107-28. PubMed ID: 10312103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review on economic evaluations of school-based lifestyle interventions targeting weight-related behaviours among 4-12 year olds: Issues and ways forward.
    Oosterhoff M; Bosma H; van Schayck OCP; Evers SMAA; Dirksen CD; Joore MA
    Prev Med; 2018 Sep; 114():115-122. PubMed ID: 29959951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the societal approach wide enough to include relatives? Incorporating relatives' costs and effects in a cost-effectiveness analysis.
    Davidson T; Levin LA
    Appl Health Econ Health Policy; 2010; 8(1):25-35. PubMed ID: 20038191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the time costs of exercise: a proposed measuring method and a pilot study.
    Hagberg LA; Lindholm L
    Cost Eff Resour Alloc; 2010 May; 8():9. PubMed ID: 20459761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing the economic consequences of work injury and illness: a comparison of methods and findings.
    Weil D
    Am J Ind Med; 2001 Oct; 40(4):418-37. PubMed ID: 11598992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?
    Rowen D; Rivero-Arias O; Devlin N; Ratcliffe J
    Pharmacoeconomics; 2020 Apr; 38(4):325-340. PubMed ID: 31903522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of QALYS and the welfare implications of survivor consumption and leisure forgone.
    Nyman JA
    Health Econ; 2011 Jan; 20(1):56-67. PubMed ID: 19946890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time.
    Grosse SD; Pike J; Soelaeman R; Tilford JM
    Pharmacoeconomics; 2019 Apr; 37(4):461-473. PubMed ID: 30953263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.
    Knies S; Severens JL; Ament AJ; Evers SM
    Value Health; 2010 Aug; 13(5):519-27. PubMed ID: 20712601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
    Prosser LA; Hammitt JK; Keren R
    Pharmacoeconomics; 2007; 25(9):713-26. PubMed ID: 17803331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China.
    Jiang S; Wang Y; Si L; Zang X; Gu YY; Jiang Y; Liu GG; Wu J
    BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35977755
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.